HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Ständer Selected Research

Prurigo

10/2022Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances.
4/2022Worst itch numerical rating scale for prurigo nodularis: a psychometric evaluation.
3/2022Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open-label extension phase.
1/2022Improvement of chronic nodular prurigo with baricitinib.
12/2019Neurokinin 1 receptor antagonists exhibit peripheral effects in prurigo nodularis including reduced ERK1/2 activation.
8/2014[Therapy of prurigo nodularis].
9/2006[Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus].
12/2004[Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients].
5/2003[Antipruritic effects of pimecrolimus and tacrolimus].
3/2001Treatment of prurigo nodularis with topical capsaicin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Ständer Research Topics

Disease

34Pruritus (Itching)
10/2022 - 03/2001
10Prurigo
10/2022 - 03/2001
7Atopic Dermatitis (Atopic Eczema)
08/2022 - 05/2003
5Skin Diseases (Skin Disease)
12/2019 - 05/2003
4Psoriasis (Pustulosis Palmaris et Plantaris)
04/2021 - 05/2003
2Bullous Pemphigoid (Pemphigoid)
04/2021 - 09/2001
2Hypersensitivity (Allergy)
09/2018 - 08/2013
2Food Hypersensitivity (Food Allergy)
09/2012 - 08/2012
2Pain (Aches)
07/2012 - 03/2001
2Contact Dermatitis (Eczema, Contact)
05/2007 - 09/2006
2Dermatitis
12/2004 - 05/2003
1Tinea (Ringworm)
08/2021
1Blister (Bulla)
04/2021
1Netherton Syndrome
02/2021
1Skin Neoplasms (Skin Cancer)
12/2020
1Wounds and Injuries (Trauma)
12/2020
1Scabies (Sarcoptic Mange)
11/2020
1Alopecia Areata
10/2020
1Cholestasis
02/2017
1Neuralgia (Stump Neuralgia)
01/2017
1Radiculopathy (Radiculopathy, Cervical)
01/2017
1Pemphigus (Pemphigus Vulgaris)
01/2017
1Erythema
07/2016
1Amyloidosis
07/2016
1Polyneuropathies (Polyneuropathy)
06/2016
1Disease Progression
05/2014
1Drug Hypersensitivity Syndrome
08/2013
1Chronic Urticaria
09/2010
1Cutaneous Leishmaniasis
04/2010
1Solar Urticaria
06/2008
1Burns
09/2006
1Diarrhea
12/2004
1Lymphoma (Lymphomas)
12/2004
1Vomiting
12/2004
1Headache (Headaches)
12/2004
1Fatigue
12/2004
1Dizziness (Lightheadedness)
12/2004

Drug/Important Bio-Agent (IBA)

8AntipruriticsIBA
12/2019 - 03/2001
5Capsaicin (Zostrix)FDA Link
09/2018 - 03/2001
4Pharmaceutical PreparationsIBA
05/2014 - 06/2004
4Histamine Antagonists (Antihistamines)IBA
07/2009 - 05/2006
3EmollientsIBA
06/2017 - 01/2005
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2017 - 01/2005
2Nalbuphine (Nubain)FDA LinkGeneric
04/2022 - 03/2022
2Neurokinin-1 Receptor AntagonistsIBA
05/2021 - 12/2019
2dupilumabIBA
02/2021 - 10/2020
2Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
12/2019 - 11/2019
2CytokinesIBA
09/2018 - 09/2010
2NeuropeptidesIBA
05/2007 - 03/2001
2Calcineurin InhibitorsIBA
05/2007 - 05/2003
2Cannabinoid Receptor AgonistsIBA
09/2006 - 05/2006
2Starch (Cornstarch)IBA
06/2004 - 12/2002
1nemolizumabIBA
10/2022
1abrocitinibIBA
08/2022
1baricitinibIBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
08/2021
1Immunoglobulin G (IgG)IBA
04/2021
1AutoantibodiesIBA
04/2021
1Biosimilar PharmaceuticalsIBA
12/2020
1Ivermectin (Mectizan)FDA Link
11/2020
1Interleukin-4 (Interleukin 4)IBA
12/2019
1Aprepitant (Emend)FDA Link
12/2019
1Substance PIBA
11/2019
1crisaboroleIBA
09/2019
1NickelIBA
09/2018
1MentholFDA Link
06/2017
1Transaminases (Aminotransferases)IBA
02/2017
1Bile Acids and Salts (Bile Acids)IBA
02/2017
1Gonadal Steroid Hormones (Sex Hormones)IBA
02/2017
1ProgesteroneFDA LinkGeneric
02/2017
1Analgesics (Analgesic Drugs)IBA
01/2017
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2017
1Minocycline (Cyclops)FDA LinkGeneric
01/2017
1Niacinamide (Nicotinamide)FDA LinkGeneric
01/2017
1Doxycycline (Periostat)FDA LinkGeneric
07/2016
1N,N-di-n-propylserotonin (NDPS)IBA
06/2016
1tofacitinibIBA
06/2016
1Chemokine ReceptorsIBA
04/2010
1azelastine (Optivar)FDA LinkGeneric
07/2009
1Histamine H1 AntagonistsIBA
07/2009
1levocetirizineFDA LinkGeneric
07/2009
1desloratadine (Aerius)FDA LinkGeneric
07/2009
1fexofenadine (Allegra)FDA LinkGeneric
07/2009
1Histamine Receptors (Histamine Receptor)IBA
05/2007
1Histamine (Histamine Dihydrochloride)FDA Link
05/2007
1Irritants (Vesicants)IBA
05/2007
1Tryptases (Tryptase)IBA
05/2007
1PAR-2 ReceptorIBA
05/2007
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
09/2006
1Ethanolamine (Colamine)IBA
09/2006
1Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
05/2006
1Narcotic Antagonists (Opioid Antagonists)IBA
12/2004
1Naltrexone (ReVia)FDA LinkGeneric
12/2004
1Opioid Receptors (Opioid Receptor)IBA
12/2004
1Opiate AlkaloidsIBA
12/2004

Therapy/Procedure

26Therapeutics
07/2020 - 03/2001
2Aftercare (After-Treatment)
06/2017 - 08/2016
2Phototherapy (Light Therapy)
12/2015 - 01/2005
1Lasers (Laser)
12/2020
1Contraindications
01/2017